Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PFIZER INC

  • FDA Approval
  • Feb. 17, 2023, 22:29 UTC
  • 30
  • 0 comments

FDA approve BEVACIZUMAB-BVZR

Comment Full text

CHIESI FARMACEUTICI SPA

  • FDA Approval
  • Feb. 17, 2023, 20:50 UTC
  • 29
  • 0 comments

FDA approve VELMANASE ALFA-TYCV

Comment Full text

COVIS

  • FDA Approval
  • Feb. 17, 2023, 20:34 UTC
  • 29
  • 0 comments

FDA approve CICLESONIDE

Comment Full text

COVIS

  • FDA Approval
  • Feb. 17, 2023, 20:34 UTC
  • 27
  • 0 comments

FDA approve CICLESONIDE

Comment Full text

RUBICON

  • FDA Approval
  • Feb. 17, 2023, 12:38 UTC
  • 26
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

AMNEAL

  • FDA Approval
  • Feb. 17, 2023, 12:38 UTC
  • 26
  • 0 comments

FDA approve MAGNESIUM SULFATE

Comment Full text

INGENUS PHARMS LLC

  • FDA Approval
  • Feb. 16, 2023, 22:25 UTC
  • 28
  • 0 comments

FDA approve LIFITEGRAST

Comment Full text

GLAXOSMITHKLINE LLC

  • FDA Approval
  • Feb. 16, 2023, 21:46 UTC
  • 28
  • 0 comments

FDA approve BELIMUMAB

Comment Full text

HUMAN GENOME SCIENCES INC.

  • FDA Approval
  • Feb. 16, 2023, 21:43 UTC
  • 28
  • 0 comments

FDA approve BELIMUMAB

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • Feb. 16, 2023, 21:40 UTC
  • 28
  • 0 comments

FDA approve IPILIMUMAB

Comment Full text
  • Previous
  • 879
  • 880
  • 881
  • 882
  • 883
  • Next

Search

News categories

  • Technical Exchange News(12226)
  • Event(6229)
  • SEC News(264751)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154624)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin